Multistate model to predict heart failure hospitalizations and all-cause mortality in outpatients with heart failure with reduced ejection fraction

Circulation: Heart Failure

Volumn 9, Issue 8, 2016, Pages

  Upshaw, Jenica N ^a   Konstam, Marvin A ^a   Van Klaveren, David ^a,b   Noubary, Farzad ^a   Huggins, Gordon S ^a   Kent, David M ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

death; heart failure; hospitalization

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; CALIBRATION; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERNAL VALIDITY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; VALIDATION STUDY; AGED; CAUSE OF DEATH; DECISION SUPPORT SYSTEM; DISEASE COURSE; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MORTALITY; OUTPATIENT; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK FACTOR; TIME FACTOR;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CAUSE OF DEATH; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LOSARTAN; MALE; MIDDLE AGED; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84983516277     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.003146     Document Type: Article

References (35)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad
2. Barker WH, Mullooly JP, Getchell W, Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 2006 113 799 805. doi: 10.1161/CIRCULATIONAHA.104.492033
3. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ, Trends in heart failure incidence and survival in a community-based population. JAMA 2004 292 344 350. doi: 10.1001/jama.292.3.344
4. Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, Roger VL, Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol 2009 54 1695 1702. doi: 10.1016/j.jacc.2009.08.019
5. Jencks SF, Williams MV, Coleman EA, Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009 360 1418 1428. doi: 10.1056/NEJMsa0803563
6. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM, Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997 95 2660 2667
7. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M, The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006 113 1424 1433. doi: 10.1161/CIRCULATIONAHA.105.584102
8. Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M, Katus HA, Clark AL, Cleland JG, Zugck C, Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status-do we need specificity for sex and beta-blockers? Int J Cardiol 2011 147 74 78. doi: 10.1016/j.ijcard.2009.08.005
9. Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG, Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm 2012 9 42 46. doi: 10.1016/j.hrthm.2011.08.031
10. Bilchick KC, Stukenborg GJ, Kamath S, Cheng A, Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 2012 60 1647 1655. doi: 10.1016/j.jacc.2012.07.028
11. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB, Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006 27 65 75. doi: 10.1093/eurheartj/ehi555
12. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S, A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 2004 116 300 304. doi: 10.1016/j.amjmed.2003.09.035
13. Kearney MT, Nolan J, Lee AJ, Brooksby PW, Prescott R, Shah AM, Zaman AG, Eckberg DL, Lindsay HS, Batin PD, Andrews R, Fox KA, A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors. Eur J Heart Fail 2003 5 489 497
14. Rickli H, Kiowski W, Brehm M, Weilenmann D, Schalcher C, Bernheim A, Oechslin E, Brunner-La Rocca HP, Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure. J Am Coll Cardiol 2003 42 116 122
15. Adlam D, Silcocks P, Sparrow N, Using BNP to develop a risk score for heart failure in primary care. Eur Heart J 2005 26 1086 1093. doi: 10.1093/eurheartj/ehi178
16. Myers J, Arena R, Dewey F, Bensimhon D, Abella J, Hsu L, Chase P, Guazzi M, Peberdy MA, A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am Heart J 2008 156 1177 1183. doi: 10.1016/j.ahj.2008.07.010
17. Leyva F, Foley PW, Stegemann B, Ward JA, Ng LL, Frenneaux MP, Regoli F, Smith RE, Auricchio A, Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Heart 2009 95 1619 1625. doi: 10.1136/hrt.2009.173880
18. Vazquez R, Bayes-Genis A, Cygankiewicz I, Pascual-Figal D, Grigorian-Shamagian L, Pavon R, Gonzalez-Juanatey JR, Cubero JM, Pastor L, Ordonez-Llanos J, Cinca J, de Luna AB, MUSIC Investigators The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur Heart J 2009 30 1088 1096. doi: 10.1093/eurheartj/ehp032
19. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM, Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail 2011 4 27 35. doi: 10.1161/CIRCHEARTFAILURE.109.932996
20. Subramanian D, Subramanian V, Deswal A, Mann DL, New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail 2011 4 456 462. doi: 10.1161/CIRCHEARTFAILURE.110.958496
21. Huynh BC, Rovner A, Rich MW, Identification of older patients with heart failure who may be candidates for hospice care: development of a simple four-item risk score. J Am Geriatr Soc 2008 56 1111 1115. doi: 10.1111/j.1532-5415.2008.01756.x
22. Herrmann R, Sandek A, von Haehling S, Doehner W, Schmidt HB, Anker SD, Rauchhaus M, Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters. Int J Cardiol 2012 156 62 68. doi: 10.1016/j.ijcard.2010.10.028
23. Cubbon RM, Woolston A, Adams B, Gale CP, Gilthorpe MS, Baxter PD, Kearney LC, Mercer B, Rajwani A, Batin PD, Kahn M, Sapsford RJ, Witte KK, Kearney MT, Prospective development and validation of a model to predict heart failure hospitalisation. Heart 2014 100 923 929. doi: 10.1136/heartjnl-2013-305294
24. de Wreede LC, Fiocco M, Putter H, The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed 2010 99 261 274. doi: 10.1016/j.cmpb.2010.01.001
25. Putter H, Fiocco M, Geskus RB, Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007 26 2389 2430. doi: 10.1002/sim.2712
26. Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA, HEAAL Investigators Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 2009 374 1840 1848. doi: 10.1016/S0140-6736(09)61913-9
27. Konstam MA, Poole-Wilson PA, Dickstein K, Drexler H, Justice SJ, Komajda M, Malbecq W, Martinez FA, Neaton JD, Riegger GA, Guptha S, Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor. Eur J Heart Fail 2008 10 899 906. doi: 10.1016/j.ejheart.2008.07.004
28. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 225 237. doi: 10.1056/NEJMoa043399
29. Johnson BK, Garberich RF, Henry TD, Katsiyiannis WT, Sengupta J, Kalra A, Hauser RG, Lardy ME, Newell MC, Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system. Heart Rhythm 2016 13 538 546. doi: 10.1016/j.hrthm.2015.10.019
30. Narayanan K, Reinier K, Uy-Evanado A, Teodorescu C, Chugh H, Marijon E, Gunson K, Jui J, Chugh SS, Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community. Circulation 2013 128 1733 1738. doi: 10.1161/CIRCULATIONAHA.113.002539
31. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 2008 1 98 106. doi: 10.1161/CIRCHEARTFAILURE.108.772228
32. Dahabreh IJ, Kent DM, Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011 305 822 823. doi: 10.1001/jama.2011.163
33. Ouwerkerk W, Voors AA, Zwinderman AH, Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart Fail 2014 2 429 436. doi: 10.1016/j.jchf.2014.04.006
34. Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, Woodward M, Patel A, McMurray J, MacMahon S, Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail 2014 2 440 446. doi: 10.1016/j.jchf.2014.04.008
35. Alba AC, Agoritsas T, Jankowski M, Courvoisier D, Walter SD, Guyatt GH, Ross HJ, Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail 2013 6 881 889. doi: 10.1161/CIRCHEARTFAILURE.112.000043